A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS)
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-positive Breast Cancer|Musculoskeletal Complications|Progesterone Receptor-positive Breast Cancer|Recurrent Breast Cancer|Stage IA Breast Cancer|Stage IB Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: anastrozole|OTHER: questionnaire administration|OTHER: laboratory biomarker analysis|OTHER: pharmacogenomic studies
Sponsor: Eastern Cooperative Oncology Group
Collaborators: National Cancer Institute (NCI)